{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-135381","form_type":"8-K","ticker":"FDMT","cik":"0001650648","company_name":"4D Molecular Therapeutics, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.108297+00:00","generated_at":"2026-05-29T04:44:12.219241+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"RA Capital exchanges 535k FDMT shares for pre-funded warrant at $0.0001 strike","bullets":["RA Capital Healthcare Fund exchanged 535,000 shares of common stock for a pre-funded warrant to purchase 535,000 shares at $0.0001 per share.","Warrant is immediately exercisable, never expires, and includes a 9.99% beneficial ownership blocker.","Issued under Section 3(a)(9) exemption; no new cash proceeds to the company.","Warrant terms adjust for stock splits, dividends, and asset distributions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-135381","json":"https://secwatch.observer/filing/0000950170-24-135381.json","markdown":"https://secwatch.observer/filing/0000950170-24-135381.md","text":"https://secwatch.observer/filing/0000950170-24-135381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650648/000095017024135381/0000950170-24-135381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650648/000095017024135381/fdmt-20241206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:44:12.219241+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}